Key points are not available for this paper at this time.
### Key messages > This paper explains the importance of extrapolating beyond the end of trials to estimate the long term benefits associated with new treatments, why this is done, and the limitations of various approaches. Policy makers worldwide use economic evaluation to inform decisions when
Latimer et al. (Tue,) studied this question.